Ascendis Health Limited (JSE:ASC) News - Financial Information of Proposed Disposals and Withdrawal of Cautionary

 Ascendis Health Limited
 (Registration number 2008/005856/06)
 (Incorporated in the Republic of South Africa)
 Share code: ASC
 ISIN: ZAE000185005
 (“Ascendis Health” or “the Company”)


                FINANCIAL INFORMATION OF PROPOSED DISPOSALS AND WITHDRAWAL OF CAUTIONARY


Shareholders are referred to the announcement published on 1 February 2022 advising of the Proposed Disposals for the full
recapitalisation of the Company (“1 February Announcement”). The terms used in this announcement bear the same
meaning as those defined in the 1 February Announcement.

1.   FINANCIAL INFORMATION OF PROPOSED DISPOSALS

The financial information relating to Ascendis Medical, Ascendis Pharma and Nimue, respectively, is shown below:

1.1. Ascendis Medical
     The net asset value of Ascendis Medical as at 31 December 2021, being the date of the last published (six month interim)
     financial information of Ascendis Health, was R289 million. The unaudited loss after tax attributable to Ascendis Medical
     for the six months ended 31 December 2021 was R259 million.

1.2. Ascendis Pharma
     The net asset value of Ascendis Pharma as at 31 December 2021, being the date of the last published (six month interim)
     financial information of Ascendis Health, was R117 million. The unaudited profit after tax attributable to Ascendis
     Pharma for the six months ended 31 December 2021 was R22 million.

1.3. Nimue
     The net asset value of Nimue as at 31 December 2021, being the date of the last published (six month interim) financial
     information of Ascendis Health, was R32 million. The unaudited profit after tax attributable to Nimue for the six months
     ended 31 December 2021 was R5 million.

The financial information was prepared in accordance with International Financial Reporting Standards and the Companies
Act, 2008 (Act 71 of 2008), as amended and extracted from the unaudited interim financial statements of Ascendis for the
six months ended 31 December 2022. The pro forma financial effects of the Proposed Disposals will be detailed in the Circular
referred to in the 1 February Announcement.

2.   WITHDRAWAL OF CAUTIONARY

Pursuant to the publication of the financial information contained in paragraph 1 above, Shareholders are advised that
caution is no longer required when dealing in their Ascendis Health shares.

The Board accepts responsibility for the information contained in this announcement as it pertains to Ascendis Health. To
the best of the Board's knowledge and belief, the information contained in this announcement as it pertains to Ascendis
Health is true and nothing has been omitted which is likely to affect the importance of such information.


15 March 2022
Bryanston

Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 15-03-2022 12:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.